AGP Executive Report
Last update: 7 hours agoMental Health Access Gap: The Dutch mental health sector says about 62,500 adults with serious mental illness are not receiving care and have effectively dropped out of the system, with “handover moments” like discharge, moving house or leaving prison blamed for people falling out of support. Housing Pressure: The report highlights a mismatch between need and availability of social housing for people leaving sheltered accommodation, worsening the risk of relapse and homelessness. Cancer Care Value for Dutch Patients: A Dutch cost-effectiveness study finds early MR-HIFU for uncomplicated non-spinal bone metastases is more effective than standard radiotherapy but at a higher cost, while delayed MR-HIFU is closer to radiotherapy on price. Rare Disease Reimbursement: In Ireland, the HSE would need a significant price cut for Biogen’s Skyclarys to be covered for Friedreich’s ataxia, with opportunity costs a key concern. EU Health-Linked Packaging Rules: New EU rules tighten limits on PFAS “forever chemicals” in food-contact packaging, aiming to reduce long-term health risks. Healthcare Tech in the Netherlands: Bruker plans to expand human physiology-relevant disease models with a majority investment in Dutch MIMETAS, bringing organ-on-a-chip platforms into broader drug development workflows.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://ml.globenewswire.com/Resource/Download/b0be38a8-093a-4d2c-9f28-3d6cf9e92e17/adobe-express-file.jpg)
